The global nasal cannula market is estimated to be valued at US$ 7.7 Billion in 2023 and is expected to exhibit a CAGR of 6.4% during the forecast period (2023-2030).
Report Coverage |
Report Details |
Base Year: |
2022 |
Market Size in 2023: |
US$ 7.7 Bn |
Historical Data for: |
2018 to 2021 |
Forecast Period: |
2023 - 2030 |
Forecast Period 2023 to 2030 CAGR: |
6.40% |
2030 Value Projection: |
US$ 11.89 Bn |
Global Nasal Cannula Market Share (%), By Product Type, 2023
The nasal cannula is a device that is used for supplying oxygen or increasing the airflow of oxygen to a patient suffering from respiratory diseases such as asthama. The device is made up of lightweight plastic or silicon tubes which are placed in the nostrils of the patient for oxygen supply. The other end of this tube is connected to an oxygen generator or flow meter. The nasal tube carries about 1-3 liters of oxygen per minute. It can be different as per the requirements of the patients. A nasal cannula is a medical device to provide supplemental oxygen therapy to people who have lower oxygen levels. There are two types of nasal cannulas: low flow and high flow. The device has two prongs and sits below the nose.
Market Dynamics
Market players are involved in research and development activities to develop treatments for respiratory diseases. This is expected to increase the growth of the nasal cannula market over the forecast period. For instance, in Karger, which is a database where scientific and medical-related articles and the latest research in life sciences are published, In February 2020, a study published about clinical evidence of nasal high flow therapy (NHFT) for COPD (Chronic Obstructive Pulmonary Disease) patients stated that studies were conducted on patients with different medical conditions, such as long-term NHFT in stable patients with COPD, chronic bronchiectasis, chronic hypoxemic failure, and chronic hypercapnic respiratory failure , where this study resulted Because compliance with nasal high-flow therapy required for COPD or bronchiectasis was 1.6 hours. In case of chronic hypoxemia he needed 6 hours per day and in chronic hypercapnia he needed 20 liters/min for 6 weeks.
Key features of the study:
- This report provides an in-depth analysis of the global nasal cannula market and provides market size (US$ Billion) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- The study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global nasal cannula market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Medtronic, Devex,Edwards Lifesciences Corporation, Terumo Corporation, LivaNova PLC, medin Medical Innovations GmbH, Flexicare (Group) Limited, Medline Industries, LP, Teleflex Incorporated, Vapotherm, Salter Labs, Well Lead Medical Co., Ltd., Drive Devilbiss International, Allied Medical Limited, Besmed Health Business Corp., Fairmont Medical, Smiths Medical, Fisher & Paykel Healthcare Limited., ResMed
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global nasal cannula market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global nasal cannula market.
Detailed Segmentation:
- By Product Type:
- Curved prong cannula
- Flared prong cannula
- Straight prong cannula
- Curved and flared prong cannula
- By Material:
- By Application:
- Asthma
- Lung cancer
- Chronic bronchitis
- Pulmonary embolism
- COPD
- Cystic fibrosis
- Pneumonia
- Others
- By End User:
- Hospital
- Long term care center
- Home care settings
- Ambulatory surgical centers
- Others
- By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
- Company Profiles
- Medtronic
- Devex
- Edwards Lifesciences Corporation
- Terumo Corporation
- LivaNova PLC
- medin Medical Innovations GmbH
- Flexicare (Group) Limited
- Medline Industries, LP
- Teleflex Incorporated
- Vapotherm
- Salter Labs
- Well Lead Medical Co., Ltd.
- Drive Devilbiss International
- Allied Medical Limited
- Besmed Health Business Corp.
- Fairmont Medical
- Smiths Medical
- Fisher & Paykel Healthcare Limited.
- ResMed